Jessica L Wall - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Journal of the American Board of Family Medicine : JABFM|January 16, 2016

Translating New Lung Cancer Screening Guidelines into Practice: The Experience of One Community HospitalChristy J W Ledford, Breanna L Gawrys, Jessica L Wall, et al.

Journal of Neurochemistry|May 21, 2024

Characterization of tritiated JNJ-GluN2B-5 (3-[3H] 1-(azetidin-1-yl)-2-(6-(4-fluoro-3-methyl-phenyl)pyrrolo[3,2-b]pyridin-1-yl)ethanone), a high affinity GluN2B radioligand with selectivity over sigma receptorsJeffrey Schoellerman, Brian Lord, Anindya Bhattacharya, et al.

Bioorganic & Medicinal Chemistry Letters|December 29, 2015

Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonistsMichael K Ameriks, Hong Ao, Nicholas I Carruthers, et al.

ACS Medicinal Chemistry Letters|March 21, 2019

1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric ModulatorsChrista C Chrovian, Akinola Soyode-Johnson, Jessica L Wall, et al.

Journal of Medicinal Chemistry|February 9, 2023

Discovery of a Series of Substituted 1H-((1,2,3-Triazol-4-yl)methoxy)pyrimidines as Brain Penetrants and Potent GluN2B-Selective Negative Allosteric ModulatorsChristine F Gelin, Brice Stenne, Heather Coate, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Journal of the American Board of Family Medicine : JABFM|January 16, 2016

Translating New Lung Cancer Screening Guidelines into Practice: The Experience of One Community HospitalChristy J W Ledford, Breanna L Gawrys, Jessica L Wall, et al.

Journal of Neurochemistry|May 21, 2024

Characterization of tritiated JNJ-GluN2B-5 (3-[3H] 1-(azetidin-1-yl)-2-(6-(4-fluoro-3-methyl-phenyl)pyrrolo[3,2-b]pyridin-1-yl)ethanone), a high affinity GluN2B radioligand with selectivity over sigma receptorsJeffrey Schoellerman, Brian Lord, Anindya Bhattacharya, et al.

Bioorganic & Medicinal Chemistry Letters|December 29, 2015

Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonistsMichael K Ameriks, Hong Ao, Nicholas I Carruthers, et al.

ACS Medicinal Chemistry Letters|March 21, 2019

1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric ModulatorsChrista C Chrovian, Akinola Soyode-Johnson, Jessica L Wall, et al.

Journal of Medicinal Chemistry|February 9, 2023

Discovery of a Series of Substituted 1H-((1,2,3-Triazol-4-yl)methoxy)pyrimidines as Brain Penetrants and Potent GluN2B-Selective Negative Allosteric ModulatorsChristine F Gelin, Brice Stenne, Heather Coate, et al.

Pageof 1